Iranzu
Iranzu Gonzalez De La Tajada, Navarra ES
Patent application number | Description | Published |
---|---|---|
20090217390 | Non-human animal sarcoma model - The invention disclosed in this application relates to a method designed to obtain a non-human animal model for sarcoma characterised in that it comprises: transfecting cells derived from a multipotent mesenchymal cell line with an expression vector that contains a polynucleotide which encodes a fusion protein selected from EWS-FLI1, EWS-ERG, EWS-ETV1, EWS-ETV4, EWS-FEV, EWS-ATF1, EWS-WT1, EWS-NR4A3 and EWS-DDIT3; and injecting said transfected cells in the animal that is the model subject. Similarly, this invention relates to the animal model itself and its applications, as well as the transfected cell line and the applications thereof. | 08-27-2009 |
Iranzu Gonzalez De La Tajada, Pamplona (navarra) ES
Patent application number | Description | Published |
---|---|---|
20120308517 | COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS AND TUMOURAL DISEASES - The present invention relates to the use of compositions comprising a type III interferon and oncostatin M and to the use of said compositions for the treatment and prevention of infectious and neoplastic diseases. | 12-06-2012 |
Iranzu González De La Tajada, Pamplona-Navarra ES
Patent application number | Description | Published |
---|---|---|
20110195047 | ONCOSTATIN M AS PROMOTER OF IMMUNOSTIMULATORY ACTIVITY OF HUMAN EPITHELIAL CELLS - The invention relates to the use of oncostatin M (OSM), an OSM receptor (OSMR) agonist, or a combination of OSM or a OSMR agonist with an interferon type I; in the manufacture of a medicament for enhancing the immunostimulatory activity of epithelial cells in a human. | 08-11-2011 |